HOXB-AS1: A Drug Target / Disease Biomarker (G100874362)

Target Name: HOXB-AS1

NCBI ID: G100874362

HOXB-AS1

Other Name(s): HOXB3OS | HOXB cluster antisense RNA 1

HOXB-AS1: A Drug Target / Disease Biomarker

Human oxylipin receptor subfamily A member 1 (HOXB-AS1) is a protein that is expressed in various tissues throughout the body. It is a potential drug target and has been identified as a biomarker for various diseases, including cancer, obesity, and cardiovascular disease.

HOXB-AS1 is a member of the human oxylipin receptor subfamily A, which is a family of transmembrane proteins that are involved in the regulation of lipid metabolism. These proteins are characterized by the presence of a nucleotide-binding oligomerization domain (NOD), which is responsible for binding to small molecules in the cell membrane.

HOXB-AS1 is a 21-kDa protein that is expressed in various tissues, including the brain, heart, liver, and pancreas. It is highly expressed in the liver, with lower levels found in the heart and pancreas. It is also expressed in the placenta, which suggests that it may be involved in fetal development and growth.

HOXB-AS1 has been shown to play a role in the regulation of lipid metabolism and to be involved in the development and progression of various diseases. One of the most significant findings related to HOXB-AS1 is its role in the regulation of obesity.

Obesity is a serious public health issue that is associated with a range of health problems, including cardiovascular disease, diabetes, and certain types of cancer. It is estimated that the number of obese adults in the United States has reached 42 million, and this number is projected to reach 80 million by the end of the 21st century.

HOXB-AS1 has been shown to be involved in the regulation of lipid metabolism and in the development of obesity. Studies have shown that HOXB-AS1 is highly expressed in obese individuals and that it is involved in the regulation of lipid metabolism.

One of the ways that HOXB-AS1 is involved in the regulation of lipid metabolism is by regulating the levels of lipids in the bloodstream. HOXB-AS1 has been shown to play a role in the regulation of lipid transport and metabolism, which may be related to the regulation of body weight.

Another way that HOXB-AS1 is involved in the regulation of lipid metabolism is by regulating the production of fat in the body. HOXB-AS1 has been shown to play a role in the regulation of lipid metabolism and in the production of fat.

HOXB-AS1 has also been shown to be involved in the regulation of inflammation, which is a key factor in the development of many diseases, including obesity.

In addition to its role in the regulation of lipid metabolism, HOXB-AS1 has also been shown to be involved in the regulation of other processes in the body. For example, it has been shown to play a role in the regulation of cell growth and the development of cancer.

HOXB-AS1 is also a potential drug target, as it has been shown to be involved in the regulation of various physiological processes in the body. Studies have shown that HOXB-AS1 is involved in the regulation of cell signaling, DNA replication, and cell growth.

HOXB-AS1 has also been shown to be involved in the regulation of pain perception and the development of chronic pain. This suggests that it may be a potential drug target for the treatment of chronic pain.

In conclusion, HOXB-AS1 is a protein that is involved in a variety of physiological processes in the body. Its role in the regulation of lipid metabolism and its potential as a drug target make it an attractive target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of HOXB-AS1 in the regulation of lipid metabolism and its potential as a drug target.

Protein Name: HOXB Cluster Antisense RNA 1

The "HOXB-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXB-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets